Loading...

Grown Rogue International Inc.

GRUSF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.32
$0.002(0.75%)
U.S. Market opens in 14h 21m

Grown Rogue International Inc. (GRUSF) Stock Overview

Explore Grown Rogue International Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap81.1M
P/E Ratio28.80
EPS (TTM)$0.01
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$0.40
3 Months$0.16
1 Year Target$0.15

GRUSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grown Rogue International Inc. (GRUSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.15.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.80 and a market capitalization of 81.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.75%
5-Day Change
13.86%
1-Month Change
6.53%
3-Month Change
-20.37%
6-Month Change
-21.26%
Year-to-Date (YTD) Change
-37.10%
1-Year Change
-21.33%
3-Year Change
131.79%
5-Year Change
69.10%
All-Time (Max) Change
-98.57%

Contact Information

https://www.grownrogue.com
458 226 2100
550 Airport Road, Medford, OR, 97504

Company Facts

204 Employees
IPO DateOct 15, 2010
CountryUS
Actively Trading

Frequently Asked Questions